Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omyst is an over-the-counter **topical herbal first aid spray** developed by Herbal Intervention and formulated by Dr. Noreen Mulvanerty. It is described as a patented product made from organically grown medicinal herbs including calendula, yarrow, plantain, and wild roses extracted in alcohol, and is marketed for minor cuts, burns, scratches, insect bites, stings, rashes, and wounds. Its claimed activity is non-targeted topical antimicrobial and wound-supportive action based on the combined botanical constituents rather than a defined single molecular target; in vitro testing cited in the provided material reported greater than 99.99% contact killing of MRSA and *Staphylococcus aureus*. The product appears to be a botanical consumer health product rather than a regulated prescription pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Omyst.